Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT01513759
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT01513759
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01513759. Allocation not applicable; no masking; primary purpose treatment. Start 2012-06-07 (actual); primary completion 2013-02-17 (actual). Results posted on 2019-07-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
- Acronym
- SEATTLE II
- Condition
- Pulmonary Embolism
- Condition
- Acute Pulmonary Embolism
- Condition
- Sub-massive Pulmonary Embolism
- Condition
- Massive Pulmonary Embolism
- Condition
- Pulmonary Thromboembolism
- Intervention (Drug)
- recombinant tissue plasminogen activator
- Intervention (Device)
- EKOS EkoSonic Endovascular System
- Lead sponsor
- Boston Scientific Corporation
- Collaborator
- EKOS Corporation
Record details
- Record id
cardio:ct-nct01513759- Content hash
ed7babc8adafb14e56733238db3d581961ad44f3d64741b0632463522955becf